Skip to main content

Table 4 Seroprevalence of HIV-1, HBV, HCV and HDV among Pregnant Women

From: Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy

   Hospital Total number of positives Overall seroprevalence
Antenatal clinic 1 Antenatal clinic 2 Antenatal clinic 3
Total number tested 506 249 250 151a (%)
Rate of biomarker (%) anti-HIV-1 antibodies 11.1 8.4 3.2 85 8.5
HbsAg 6.3 8.4 4.4 64 6.4
anti-HBs 24.3 23.2 22.4 237 23.6
HBeAg 12.1 11.9 1 82 8.2
anti-Hbe 18.8 16.8 17.6 182 18.1
anti-HBc 37.0 28.4 34.8 347 34.5
anti-HCV 0.4 0.2 0.2 8 0.8
anti-HDV     40 4.0
  1. aTotal number of women infected with HIV, HBV or HCV